AZD9567
CAS: 1893415-00-3
Ref. 3D-TAD41500
| 1mg | 548.00 € | ||
| 2mg | 746.00 € | ||
| 5mg | 1,403.00 € | ||
| 10mg | 2,315.00 € | ||
| 25mg | 4,910.00 € |
Product Information
AZD9567 is a potent and selective inhibitor of the enzyme phosphodiesterase-4 (PDE4) that has been shown to reduce glucose levels in diabetic animals. It also has antiviral activity against influenza A, as well as anti-inflammatory effects in mice with experimental arthritis. AZD9567 has been studied for safety and efficacy in phase I trials for the treatment of type 2 diabetes and inflammatory diseases. The drug has a terminal half-life of 6 hours in healthy subjects and 8 hours in patients with chronic kidney disease. There are no significant changes in pro-inflammatory cytokines during chronic treatment with AZD9567 and it is well tolerated by women, making it an attractive candidate for clinical development.
Chemical properties
Technical inquiry about: 3D-TAD41500 AZD9567
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
